1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow NBI 5788: new trials by email Literature Review of NBI 5788 trials Research Report on NBI 5788
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS) NBI-5788 - Multiple Sclerosis | Phase 2 | Completed | Neurocrine Biosciences | 150 | 2003-07-01 | 2008-03-21 |
Autoimmune Diseases (1) · Multiple Sclerosis (1) · Recurrence (1)